发明公开
- 专利标题: UROKINASE-TYPE PLASMINOGEN ACTIVATOR TRANSGENIC MOUSE
- 专利标题(中): 转基因尿激酶型纤溶酶原激活剂MOUSE
-
申请号: EP13780731.9申请日: 2013-04-25
-
公开(公告)号: EP2842417A1公开(公告)日: 2015-03-04
- 发明人: KOHARA, Michinori , JISHAGE, Koichi , KAWASE, Yosuke , MUKAIDANI, Chise , OSHITA, Hiroki , HAMAMURA, Satoko
- 申请人: Tokyo Metropolitan Institute of Medical Science , Chugai Seiyaku Kabushiki Kaisha , Phoenixbio Co., Ltd.
- 申请人地址: 1-6, Kamikitazawa 2-chome Setagaya-ku Tokyo 156-8506 JP
- 专利权人: Tokyo Metropolitan Institute of Medical Science,Chugai Seiyaku Kabushiki Kaisha,Phoenixbio Co., Ltd.
- 当前专利权人: Tokyo Metropolitan Institute of Medical Science,Chugai Seiyaku Kabushiki Kaisha,Phoenixbio Co., Ltd.
- 当前专利权人地址: 1-6, Kamikitazawa 2-chome Setagaya-ku Tokyo 156-8506 JP
- 代理机构: Harding, Charles Thomas
- 优先权: JP2012102814 20120427
- 国际公布: WO2013162064 20131031
- 主分类号: A01K67/027
- IPC分类号: A01K67/027 ; G01N33/15 ; G01N33/50 ; C12N15/09
摘要:
The present invention provides a mouse with liver damage, having a high degree of damage against the mouse's original hepatocytes while having a uPA gene in a heterozygous form, and a method for efficiently preparing the mouse. Specifically, the method for preparing a mouse with liver damage having the uPA gene in a heterozygous form comprises the following steps of:
(i) transforming mouse ES cells with a DNA fragment containing a liver-specific promoter/enhancer and cDNA that encodes a urokinase-type plasminogen activator operably linked under the control thereof;
(ii) injecting the transformed mouse ES cells obtained in step (i) into a host embryo;
(iii) transplanting the host embryo obtained in step (ii) via the injection of the ES cells into the uterus of a surrogate mother mouse, so as to obtain a chimeric mouse; and
(iv) crossing the chimeric mice obtained in step (iii), so as to obtain a transgenic mouse in which the DNA fragment is introduced in a heterozygous form.
(i) transforming mouse ES cells with a DNA fragment containing a liver-specific promoter/enhancer and cDNA that encodes a urokinase-type plasminogen activator operably linked under the control thereof;
(ii) injecting the transformed mouse ES cells obtained in step (i) into a host embryo;
(iii) transplanting the host embryo obtained in step (ii) via the injection of the ES cells into the uterus of a surrogate mother mouse, so as to obtain a chimeric mouse; and
(iv) crossing the chimeric mice obtained in step (iii), so as to obtain a transgenic mouse in which the DNA fragment is introduced in a heterozygous form.
公开/授权文献
- EP2842417B1 UROKINASE-TYPE PLASMINOGEN ACTIVATOR TRANSGENIC MOUSE 公开/授权日:2018-03-14
信息查询